Article Details
Retrieved on: 2017-12-18 23:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors decreased Aerie Pharmaceuticals Com (AERI) stake by 72.83% reported in 2017Q2 SEC filing. <b>Benchmark Capital</b> Advisors sold 35,925 shares as Aerie Pharmaceuticals Com (AERI)'s stock declined 8.47%. The <b>Benchmark Capital</b> Advisors holds 13,400 shares with ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here